Eight Advisory team assisted Gedeon Richter in their investment in Mithra assets Estetra and Neuralis
Eight Advisory performed a distressed buy side due diligence and assistance to Gedeon Richter.
Gedeon Richter is a global group of companies specialising in the production of medicines and medicinal products.
Mithra is a company dedicated to women’s health. Its key asset is its own-developed lead platform, based on Estetrol (E4), a unique, native estrogen. The transaction aims to acquire exclusive rights of this molecule for multiple indications and several synthetic approaches thereof, as well as worldwide rights attached to the linked product/product candidates.
The acquired assets represent a unique opportunity for Richter to further expand and deepen its presence in its core Women’s Healthcare (WHC) business worldwide.
Congratulations to all involved parties and big thanks to our team:
- Financial Due diligence: Philippe Fimmers (Partner), Joris Peers (Director), Caroline Depestel (Senior Manager), Fábio Gonçalves Viegas (Senior Manager), Alain Kabera (Senior), Carl Couvreur (Analyst)
- Tax due diligence: Christian Van Craeyvelt (Partner), Jean-Louis Vansimaeys (Manager), Ward Sandra (Analyst)
Insights
Beyond the Ceasefire: Why the Hormuz shock will outlast the reopening
29 Jun 2026
Read more
Insights
Tax as a special form of travel guidance, finally AI and never a lone warrior
5 Feb 2026
Read more
Deals
Eight Advisory advised Waterland on the sale of Onoré to IDAK Food Group
13 Jan 2026
Read more
Deals
Eight Advisory supported Kieback&Peter on the sale of a minority stake to Trane Technologies
1 Dec 2025
Read more
Deals
Eight Advisory supported CERTANIA on its acquisitions of CS Regulatory Ltd.
1 Dec 2025
Read more
Deals
Eight Advisory supported QLS on the acquisition of J&J Global Fulfilment
27 Nov 2025
Read more
Deals
Eight Advisory supported Avista Healthcare Partners and Damier Group on the acquisition of PK Benelux
26 Nov 2025
Read more
